Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVBP

ArriVent BioPharma Inc

May 22 • 04:00PM ET

26.73

-0.27 -1.00 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: BCYC AUTL RLAY NUVB KURA

| Held by: VTI XBI IWM VXF IWO IBB VTWO SCHA IWC VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.53	Insider Own	34.32%	Shs Outstand	45.31M	Perf Week	-4.09%
Market Cap	1.24B	Forward P/E	-	EPS next Y	-3.33	Insider Trans	-3.36%	Shs Float	30.59M	Perf Month	-13.77%
Enterprise Value	918.99M	PEG	-	EPS next Q	-0.97	Inst Own	69.99%	Short Float	23.24%	Perf Quarter	13.84%
Income	-145.24M	P/S	-	EPS this Y	8.44%	Inst Trans	3.84%	Short Ratio	14.46	Perf Half Y	33.45%
Sales	0.00M	P/B	3.74	EPS next Y	15.91%	ROA	-51.43%	Short Interest	7.11M	Perf YTD	32.85%
Book/sh	7.15	P/C	3.81	EPS next 5Y	31.63%	ROE	-55.17%	52W High	32.14 -16.83%	Perf Year	29.57%
Cash/sh	7.01	P/FCF	-	EPS past 3/5Y	-57.73% -29.43%	ROIC	-44.79%	52W Low	16.10 66.02%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.15% 5.52%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	6.28%	Oper. Margin	-	ATR (14)	1.49	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	13.95	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	41.08	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	13.95	EPS Q/Q	49.18%	SMA20	-7.35%	Beta	1.43	Target Price	43.75
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-0.72%	Rel Volume	0.88	Prev Close	27.00
Employees	77	LT Debt/Eq	0.00	Earnings	May 11 AMC	SMA200	19.41%	Avg Volume	491.72K	Price	26.73
IPO	Jan 26, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	-7.24% -	Trades		Volume	433,363	Change	-1.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)